Radiotherapy and PD-L1 inhibition in metastatic NSCLC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiotherapy and PD-L1 inhibition in metastatic NSCLC

Published:2017-07 Issue:7 Volume:18 Page:840-842
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

De Ruysscher Dirk

Publisher

Elsevier BV

Subject

Oncology

Reference9 articles.

1. New and emerging targeted treatments in advanced non-small-cell lung cancer;Hirsch;Lancet,2016

2. Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy;Sharabi;Lancet Oncol,2015

3. Immunological mechanisms underneath the efficacy of cancer therapy;Galluzzi;Cancer Immunol Res,2016

4. Role of local radiation therapy in cancer immunotherapy;Demaria;JAMA Oncol,2015

5. Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?;Walshaw;Br J Radiol,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis: case report and literature review;Frontiers in Oncology;2024-04-22

2. TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanism;Cancer Immunology, Immunotherapy;2022-07-06

3. Thorakale Onkologie – frühe Stadien;Der Onkologe;2022-01-23

4. An overview of the published and running randomized phase 3 clinical results of radiotherapy in combination with immunotherapy;Translational Lung Cancer Research;2021-04

5. Effect of radiotherapy on T cell and PD-1 / PD-L1 blocking therapy in tumor microenvironment;Human Vaccines & Immunotherapeutics;2021-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3